NCDB cancer bytes
NCDB trends in young women with metastatic breast cancer diagnosis since screening guideline changes were instituted(0)
Early detection of breast cancer by mammography allows women to access more favorable treatment options and has resulted in an overall reduction in mortality of approximately 20 percent to 40 percent and improved survival.1 In 2009, the U.S. Preventive Services Task Force (USPSTF) changed breast cancer screening guidelines for mammograms from every one year to […]
There will be 27,600 new diagnoses of gastric cancer and 11,010 gastric cancer-related deaths in the U.S. in 2020. Most patients with gastric cancer will succumb to their disease, and only those few patients diagnosed at an early stage can expect to be cured.1 Gastric cancer occurs with significantly higher incidence in eastern countries, which […]
Neoadjuvant and perioperative chemotherapy for localized pancreatic cancer: Leveraging small and large databases in the absence of Level 1 evidence
In the rapidly evolving clinical paradigms for localized pancreatic cancer, a combination of Level 1 data and large and small database studies can inform disease management.
The potential role of NCDB data in treating rare malignancy is explored.
This article compares demographic data of astrocytomas and glioblastomas patients documented in the NCDB, a hospital-based cancer registry, with cases in the Central Brain Tumor Registry of the U.S.
More in this category
- Current trends in prostate cancer: The role of brachytherapy
- Thyroid cancer mortality in an aging population
- Active surveillance as a treatment modality in ductal carcinoma in situ
- Endometrial cancer: An increasingly common gynecologic malignancy
- Using data to plan cancer prevention and screening activities
- Strategically reversing the rising incidence of melanoma in younger patients
- The impact of financial barriers on access to quality care in breast cancer
- Using the NCDB to explore trends in cancer